Werbung
Werbung

AHCO

AHCO logo

AdaptHealth Corp. Common Stock

10.48
USD
Gesponsert
-0.13
-1.27%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

10.48

0.00
0.00%

AHCO Ergebnisberichte

Positives Überraschungsverhältnis

AHCO übertreffen die 3 der letzten 24Schätzungen.

13%

Nächster Bericht

Datum des nächsten Berichts
23. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$849.16M
/
$0.38
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+3.52%
/
+137.50%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-0.87%
/
+11.76%

AdaptHealth Corp. Common Stock earnings per share and revenue

On 04. Nov. 2025, AHCO reported earnings of 0.16 USD per share (EPS) for Q3 25, missing the estimate of 0.24 USD, resulting in a -35.33% surprise. Revenue reached 820.31 million, compared to an expected 815.30 million, with a 0.62% difference. The market reacted with a +17.38% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of 0.38 USD, with revenue projected to reach 849.16 million USD, implying an increase of 137.50% EPS, and increase of 3.52% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Tilray Brands, Inc. Common Stock
Report Date
08. Jan. 2026 For Q2 26
Estimate
-$0.20
Aktuell
-$0.41
Überraschung
-100.98%
logo
Neogen Corp
Report Date
08. Jan. 2026 For Q2 26
Estimate
$0.05
Aktuell
$0.10
Überraschung
+78.25%
FAQ
For Q3 2025, AdaptHealth Corp. Common Stock reported EPS of $0.16, missing estimates by -35.33%, and revenue of $820.31M, 0.62% above expectations.
The stock price moved up 17.38%, changed from $9.09 before the earnings release to $10.67 the day after.
The next earning report is scheduled for 23. Feb. 2026.
Based on 10 analysts, AdaptHealth Corp. Common Stock is expected to report EPS of $0.38 and revenue of $849.16M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung